96 related articles for article (PubMed ID: 19403384)
21. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
Ping W; Jiang WY; Chen WS; Sun W; Fu XN
Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
[TBL] [Abstract][Full Text] [Related]
22. α5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1α and VEGF expression in non-small cell lung cancer.
Ma X; Jia Y; Zu S; Li R; Jia Y; Zhao Y; Xiao D; Dang N; Wang Y
Toxicol Appl Pharmacol; 2014 Jul; 278(2):172-9. PubMed ID: 24793809
[TBL] [Abstract][Full Text] [Related]
23. Metastasis-associated protein 1 nuclear expression is associated with tumor progression and clinical outcome in patients with non-small cell lung cancer.
Zhu X; Guo Y; Li X; Ding Y; Chen L
J Thorac Oncol; 2010 Aug; 5(8):1159-66. PubMed ID: 20661085
[TBL] [Abstract][Full Text] [Related]
24. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
[TBL] [Abstract][Full Text] [Related]
25. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
26. [The expression and clinical significance of HIF-1α, COX-2 and E-cadherin in patients with lung adenocarcinoma].
Gu S; Qin J
Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):219-26. PubMed ID: 21426663
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.
Yohena T; Yoshino I; Takenaka T; Kameyama T; Ohba T; Kuniyoshi Y; Maehara Y
J Thorac Oncol; 2009 Mar; 4(3):284-90. PubMed ID: 19190516
[TBL] [Abstract][Full Text] [Related]
29. Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.
Berezowska S; Galván JA; Langer R; Bubendorf L; Savic S; Gugger M; Schmid RA; Marti TM
Virchows Arch; 2017 Mar; 470(3):323-330. PubMed ID: 28062918
[TBL] [Abstract][Full Text] [Related]
30. Correlation of HIF-1α/HIF-2α expression with FDG uptake in lung adenocarcinoma.
Higashi K; Yamagishi T; Ueda Y; Ishigaki Y; Shimasaki M; Nakamura Y; Oguchi M; Takegami T; Sagawa M; Tonami H
Ann Nucl Med; 2016 Dec; 30(10):708-715. PubMed ID: 27663442
[TBL] [Abstract][Full Text] [Related]
31. MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer.
Zhou N; Wang H; Liu H; Xue H; Lin F; Meng X; Liang A; Zhao Z; Liu Y; Qian H
J Exp Clin Cancer Res; 2015 Dec; 34():157. PubMed ID: 26698569
[TBL] [Abstract][Full Text] [Related]
32. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
Yang SL; Ren QG; Wen L; Hu JL
J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
[TBL] [Abstract][Full Text] [Related]
35. KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1α.
Li X; Liu X; Xu Y; Liu J; Xie M; Ni W; Chen S
Int J Oncol; 2014 Oct; 45(4):1507-14. PubMed ID: 25051115
[TBL] [Abstract][Full Text] [Related]
36. Relationship between MTA1 and spread through air space and their joint influence on prognosis of patients with stage I-III lung adenocarcinoma.
Liu Y; Chen D; Qiu X; Duan S; Zhang Y; Li F; Chen C; Zhou Y; Chen Y
Lung Cancer; 2018 Oct; 124():211-218. PubMed ID: 30268463
[TBL] [Abstract][Full Text] [Related]
37. Metastasis-Associated Protein 1 Is Involved in Angiogenesis after Transarterial Chemoembolization Treatment.
Xue T; Feng W; Yu H; Zhu M; Fei M; Bao Y; Wang X; Ma W; Lv G; Guan J; Chen S
Biomed Res Int; 2017; 2017():6757898. PubMed ID: 28589145
[TBL] [Abstract][Full Text] [Related]
38. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Fischer C; Leithner K; Wohlkoenig C; Quehenberger F; Bertsch A; Olschewski A; Olschewski H; Hrzenjak A
Mol Cancer; 2015 Jan; 14():4. PubMed ID: 25608569
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion.
Shyu KG; Hsu FL; Wang MJ; Wang BW; Lin S
Exp Cell Res; 2007 Apr; 313(6):1181-91. PubMed ID: 17335808
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival.
Cabuk D; Basaran G; Celikel C; Dane F; Yumuk PF; Iyikesici MS; Ekenel M; Turhal NS
Oncology; 2007; 72(1-2):111-7. PubMed ID: 18025805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
